Sept. 4, 2024
The U.S. Nuclear Regulatory Commission (NRC) issued Information Notice 2024-04 Aug. 9, to inform licensees of recent reported medical events that involved the administration of therapeutic radiopharmaceuticals.

The notice is intended to notify licensed facilities and personnel of 29 medical events from federal fiscal year 2021 through 2023, caused primarily by lack of confirmation, validation or implementation of written directives. It does not provide information regarding the specialties/professions or institutions involved; however, it does mention that several of these medical events occurred due to coordination or communication issues with departments other than the department that administered the radiopharmaceutical.

Moving forward, medical licensees and authorized personnel that offer radiopharmaceutical therapies should review the notice and apply lessons learned to inter- and intra-departmental training and protocols to avoid similar medical events in the future.

If you have questions or would like more information, contact Michael Peters, American College of Radiology® Senior Director of Government Affairs.

Related ACR News

  • Focus on Scope: Latest Status of State Healthcare-Related Bills

    Overview of status of several bills in this year’s state legislative sessions related to scope of practice.

    Read more
  • Participate in the Healthcare AI Challenge at ACR 2025

    Call for ACR 2025 attendees to participate in healthcare AI challenge at the upcoming meeting.

    Read more
  • Supreme Court Hears Oral Arguments in Kennedy vs. Braidwood Case

    ACR is monitoring the Kennedy vs. Braidwood Management case, which could potentially affect full insurance coverage of at least some cancer screening exams.

    Read more